Skip to main content

Advertisement

SpringerLink
Log in

Factors Associated with Readmission After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis

  • Gastrointestinal Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Purpose

Cytoreductive surgery/hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) for peritoneal carcinomatosis is a morbid endeavor. Despite improvement in perioperative management of these patients, there are subsets of patients requiring hospital readmission after discharge. We sought to identify variables associated with readmission rates for CRS/HIPEC.

Methods

We conducted a retrospective review of CRS/HIPEC cases at the University of Cincinnati between 1999 and 2014. Patient-, tumor-, and treatment-specific characteristics were evaluated. The association between patient- and outcome-specific variables for 30- and 90-day readmission were evaluated.

Results

Of 215 CRS/HIPEC patients, the 7-, 30-, and 90-day readmission rates were 9.8 % (n = 21), 14.9 % (n = 32), and 21.4 % (n = 46), respectively. The most common reasons for readmission within 90 days included abdominal pain (n = 14), intra-abdominal abscess (n = 9), malnutrition/failure to thrive (n = 8), and bowel obstruction (n = 7). The primary factor associated with readmission at all time points (7, 30, and 90 days) was the presence of an enterocutaneous fistula (p < 0.01). Six patients (2.8 %) had multiple readmissions; 3 of these had ECF. Factors not associated with higher admission rates included sex, age, race, operative blood loss, pancreatectomy or liver resection at the index operation, and postoperative complications of wound infection, line infection, and thromboembolic events.

Conclusions

In patients undergoing CRS/HIPEC, readmission was primarily associated with poor pain control, malnutrition, and infectious complications. Patients with enterocutaneous fistula were also disproportionately readmitted multiple times. These data should inform clinicians about patients at high risk for readmission after CRS/HIPEC and encourage more comprehensive coordination of postdischarge planning and care for specific patient populations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Stitzenberg KB, Chang Y, Smith AB, Nielsen ME. Exploring the burden of inpatient admissions after major cancer surgery. J Clin Oncol. 2015;33:455–64.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Ahmad SA, Kim J, Sussman JJ, et al. Reduced morbidity following cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion. Ann Surg Oncol. 2004;11:387–92.

    Article  PubMed  Google Scholar 

  3. Stephens AD, Alderman R, Chang D, et al. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol. 1999;6:790–6.

    Article  CAS  PubMed  Google Scholar 

  4. Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221:29–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Verwaal VJ, van Tinteren H, Ruth SV, et al. Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. J Surg Oncol. 2004; 85:61–7.

    Article  PubMed  Google Scholar 

  6. Jencks SF, Williams MV, Coleman EA, et al. Rehospitalizations among patients in the medicare fee-for-service program. N Engl J Med. 2009;360:1418–28.

    Article  CAS  PubMed  Google Scholar 

  7. Jacobs BL, Zhang Y, Tan HJ, Ye Z, Skolarus TA, Hollenbeck BK. Hospitalization trends after prostate and bladder surgery: implications of potential payment reforms. J Urol. 2013;189:59–65.

    Article  PubMed  Google Scholar 

  8. Leow JJ, Gandaglia G, Sood A, et al. Readmissions after major urologic cancer surgery. Can J Urol. 2014;21:7537–46.

    PubMed  Google Scholar 

  9. Ahmad SA, Edwards MJ, Sutton JM, et al. Factors influencing readmission after pancreaticoduodenectomy: a multi-institutional study of 1302 patients. Ann Surg. 2012;256:529–37.

    Article  PubMed  Google Scholar 

  10. Hyder O, Dodson RM, Nathan H, et al. Influence of patient, physician, and hospital factors on 30-day readmission following pancreatoduodenectomy in the United States. JAMA Surg. 2013;148:1095–102.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Shah SP, Xu T, Hooker CM, et al. Why are patients being readmitted after surgery for esophageal cancer? J Thorac Cardiovasc Surg. 2015;149:1384–9.

    Article  PubMed  Google Scholar 

  12. Sundaram A, Srinivasan A, Baker S, Mittal SK. Readmission and risk factors for readmission following esophagectomy for esophageal cancer. J Gastrointest Surg. 2015;19:581–5.

    Article  PubMed  Google Scholar 

  13. Hu Y, McMurry TL, Isbell JM, Stukenborg GJ, Kozower BD. Readmission after lung cancer resection is associated with a 6-fold increase in 90-day postoperative mortality. J Thorac Cardiovasc Surg. 2014;148:2261–7.

    Article  PubMed  PubMed Central  Google Scholar 

  14. McDevitt J, Kelly M, Comber H, et al. A population-based study of hospital length of stay and emergency readmission following surgery for non-small-cell lung cancer. Eur J Cardiothorac Surg. 2013;44:e253–9.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthemic intraperitoneal versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737–43.

    Article  PubMed  Google Scholar 

  16. Jafari MD, Halabi WJ, Stamos MJ, et al. Surgical outcomes of hyperthermic intraperitoneal chemotherapy: analysis of the American College of Surgeons National Surgical Quality Improvement Program. Pacific Coast Surgical Association. JAMA. 2014;149:170–5.

    Google Scholar 

  17. Glehen O, Gilly FN, Boutitie F, et al. French Surgical Association. Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1290 patients. Cancer. 2010;116:5608–18.

    Article  PubMed  Google Scholar 

  18. Halkia E, Efstathiou E, Rogdakis A, et al. Digestive fistulas after cytoreductive surgery and HIPEC in peritoneal carcinomatosis. J BUON. 2015;20(1 suppl):S60–3.

    PubMed  Google Scholar 

  19. Haslinger M, Francesecutti V, Attwood K, et al. A contemporary analysis of morbidity and outcomes in cytoreduction/hyperthermic intraperitoneal chemoperfusion. Cancer Med. 2013;2:334–42.

    Article  PubMed  PubMed Central  Google Scholar 

  20. da Silva RG, Sugarbaker PH. Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer. J Am Coll Surg. 2006;203:878–86.

    Article  PubMed  Google Scholar 

  21. Votanopoulos KI, Swords DS, Swett KR, et al. Obesity and peritoneal surface disease: outcomes after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for appendiceal and colon primary tumors. Ann Surg Oncol. 2013;20:3899–904.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Austin F, Mavanur A, Sathaiah M, et al. Aggressive management of peritoneal carcinomatosis from mucinous appendiceal neoplasms. Ann Surg Oncol. 2013;19:1386–93.

    Article  Google Scholar 

  23. Randle RW, Doud AN, Levine EA, et al. Peritoneal surface disease with synchronous hepatic involvement treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2015;22:1634–8.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Disclosure

The authors declare no conflict of interest.

Author information

Authors and Affiliations

  1. Division of Surgical Oncology, Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, OH, USA

    Alexander S. Martin, Daniel E. Abbott MD, Dennis Hanseman, Jonathan E. Sussman, Alexander Kenkel, Parker Greiwe, Noor Saeed, Samar H. Ahmad, Jeffrey J. Sussman MD & Syed A. Ahmad MD

Authors
  1. Alexander S. Martin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel E. Abbott MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dennis Hanseman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jonathan E. Sussman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alexander Kenkel
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Parker Greiwe
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Noor Saeed
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Samar H. Ahmad
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jeffrey J. Sussman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Syed A. Ahmad MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Syed A. Ahmad MD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Martin, A.S., Abbott, D.E., Hanseman, D. et al. Factors Associated with Readmission After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis. Ann Surg Oncol 23, 1941–1947 (2016). https://doi.org/10.1245/s10434-016-5109-3

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-016-5109-3

Keywords

Search

Navigation